Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CNTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CNTA

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Centessa Pharmaceuticals PLC ADR

CNTA
Current price
15.69 USD -0.36 USD (-2.24%)
Last closed 15.96 USD
ISIN US1523091007
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 132 559 232 USD
Yield for 12 month +66.91 %
1Y
3Y
5Y
10Y
15Y
CNTA
21.11.2021 - 28.11.2021

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines. Its lead clinical-stage program includes ORX750, an orally administered OX2R agonist in a Phase 2a study for the treatment of idiopathic hypersomnia and narcolepsy type 1 and 2. The company also develops ORX142 for the treatment of neurological and neurodegenerative disorders, as well as other potential symptoms, including excessive daytime sleepiness, impaired attention, cognitive deficits, and fatigue; and ORX489 for the treatment of neuropsychiatric disorders. In addition, it offers LockBody, which is designed to selectively drive potent effector function activity, such as CD3, into the tumor microenvironment. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom. Address: 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

31.50 USD

P/E Ratio

Dividend Yield

Financials CNTA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CNTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

+6 853 000 USD

Current Quarter

+15 000 000 USD

Last Quarter

Current Year

-942 000 USD

Last Year

+6 853 000 USD

Current Quarter

+14 840 000 USD

Last Quarter

EBITDA -195 423 008 USD
Operating Margin TTM -205.18 %
Price to Earnings
Return On Assets TTM -28.58 %
PEG Ratio
Return On Equity TTM -74.44 %
Wall Street Target Price 31.50 USD
Revenue TTM 15 000 000 USD
Book Value 2.89 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 15 000 000 USD
Earnings per share -1.88 USD
Diluted Eps TTM -1.88 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation CNTA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 131.07
Price Sales TTM 142.17
Enterprise Value EBITDA 1.12
Price Book MRQ 5.52

Technical Indicators CNTA

For 52 Weeks

9.00 USD 19.09 USD
50 Day MA 12.98 USD
Shares Short Prior Month 4 468 784
200 Day MA 15.16 USD
Short Ratio 4.45
Shares Short 3 836 998
Short Percent 3.94 %